In order to make a comparison of recent cancer incidence rates between Japan and other countries, we abstracted the age-standardized incidence rates (ASRs) by three age categories (0–59, 60–74, 75+) from the Cancer Incidence in Five Continents Vol. XI (CI5) (1). International Agency for Research on Cancer provides the CI5 databases on the incidence of cancer recorded by cancer registries (regional and national) worldwide. We extracted ASRs from the following cancer registries; the United States of America, Beijing in China, Mumbai in India, Hiroshima and Osaka in Japan, the Republic Korea, Gironde in France, Hamburg in Germany, the United Kingdom and Australia from the CI5-XI database. The period of years at cancer diagnosis were from 2008 to 2012. Figure 1 shows the ASRs for lung cancer coded as C33-34 (ICD10) of males. The ASRs of males who were over 75 year old in Japan (Osaka and Hiroshima), and the Republic of Korea were higher than those in other countries or regions, while the ASRs of males in aged 0-59 and 60-74 groups were almost similar among the selected countries or regions except those in India (Mumbai). Figure 1. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Figure 1. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Figure 2 shows the ASRs for lung cancer coded as C33-34 (ICD10) of females. The ASRs of females who were over 75 year old in the United States of America, the United Kingdom, and China (Beijing) were higher (about 300 per 100,000), while those in Japan (Osaka and Hiroshima), Australia, the Republic of Korea, and Germany (Hamburg) were slightly lower (about 200 per 100,000). The ASRs of females in aged 60–74 group in the United States of America, the United Kingdom, and Germany (Hamburg) were slightly higher than those in other countries or regions. Figure 2. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Figure 2. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Overall the ASRs for lung cancer of males, in particular in over 75 year old group, were higher than those of females in each country or region. This differences in Japan (Osaka and Hiroshima) and the Republic Korea were larger than other countries or regions. Note: Data were downloaded from the Global Cancer Observatory (GCO), which was an interactive web-based platform presenting global cancer statistics (https://gco.iarc.fr/). Responsibility for this presentation and interpretation lies with the authors of this article. Reference 1 Bray F, Colombet M, Mery L, et al. , editors. Cancer Incidence in Five Continents, Vol. XI (electronic version). Lyon: International Agency for Research on Cancer. Available from: http://ci5.iarc.fr, accessed [2018/1/10]. © The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: firstname.lastname@example.org.
Japanese Journal of Clinical Oncology – Oxford University Press
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera